Partners

CULTIVATION

Specialised in the cultivation of cannabis for medical, cosmetic and nutritional purposes in a 6.4 ha greenhouse dedicated to equal parts of non-psychoactive cannabis with a high CBD content and a low THC content of less than 1%, and psychoactive cannabis with a high THC content, with a prospect to increase the footprint to 12 ha.

PROCESSING & EXTRACTION

Committed to the development and dispensing of customised cannabis-based pharmaceutical and lifestyle products, incl. the packaging and shipping in a GMP- and GLP-compliant facility for the production of pharmaceutical products for export as well as the customized active pharmaceutical ingredients’ final conditioning upon customer request.

DEVELOPMENT OF PRODUCTS

Focused on the processing of essential components of both psychoactive and non-psychoactive cannabis for medical, cosmetic and nutritional purposes in a facility with a current capacity to extract up to 5 tons of dried inflorescences per month for further processing, and a planned expansion to a processing capacity of 22 tons per month.

CULTIVATION

Algamur SA is at the beginning of the production chain, being in charge of cultivating medical-grade cannabis in a greenhouse, under strict conditions of sanitary surveillance and complying with GAP at all times.

PROCESSING & EXTRACTION

Wemblar Corp. SA completes the second stage of the production chain by extracting the essential components of the raw material sold and delivered by Algamur SA.

PRODUCT DEVELOPMENT

Dukilu Trade SA completes the third stage of the production chain. A plant with an estimated 1,250 m2 will be fully devoted to the production of pharmaceutical products from full spectrum resin and purified resin with a high CBD content delivered by Wemblar for export, as well as the final conditioning of the customized active pharmaceutical ingredients upon customer request.